LIGAND PHARMACEUTICALS INC — Director's Dealing 2016

Jan 4, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: LIGAND PHARMACEUTICALS INC (LGND)
CIK: 0000886163
Period of Report: 2015-12-31

Reporting Person: Herman Melanie J (Director of Accounting)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2015-12-31	Common Stock	J	140.0	$82.53	Acquired	3291	Direct

Footnotes

F1: Shares acquired under Ligand's employee stock purchase plan. Voluntary reporting exemption under Rule 16b-3(c).